QS insider sale notice: 42,321 RSU shares slated to sell

QS reported proposed insider sales of Class A common stock totaling 42,321 shares tied to RSU vesting on 02/24/2026.

Rhea-AI Filing Summary

QS reported proposed insider sales of Class A common stock totaling 42,321 shares tied to RSU vesting on 02/24/2026. The filing lists multiple recent dispositions by Timothy Holme and The Holme 2020 Irrevocable Trust, including sales of 166,440 shares on 12/04/2025 and other trades through 02/20/2026.

Insights

Insider Transactions Specialist

Insiders filed planned sales tied to vested RSUs and recorded multiple recent dispositions.

The filing shows 42,321 shares identified as securities to be sold on 02/24/2026 in connection with RSU vesting; this is a planned insider disposition rather than a corporate financing action.

Recent completed sales by Timothy Holme and The Holme 2020 Irrevocable Trust include multiple entries (for example, 166,440 shares on 12/04/2025 and other sales through 02/20/2026), which illustrate recent insider liquidity activity; timing and cash‑flow recipients are defined by each sale notice.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does QS's Form 144 say about planned insider sales?

The filing reports 42,321 Class A shares identified for sale tied to RSU vesting on 02/24/2026. It lists this planned disposition as compensation‑related rather than a new issuance or shelf registration.

Who conducted recent sales disclosed in the QS Form 144?

The filing lists transactions by Timothy Holme and The Holme 2020 Irrevocable Trust, including a 166,440-share sale on 12/04/2025 and multiple later dispositions through 02/20/2026.

Are the shares to be sold by QS the result of new issuance?

The shares to be sold are tied to RSU vesting and labeled as compensation on 02/24/2026, indicating they arise from equity awards rather than a primary public offering or registered shelf sale.

Does the Form 144 indicate who receives proceeds from these sales?

The filing identifies the selling holders and dates of prior sales but does not state uses of proceeds; proceeds flow to the selling holders as disclosed in each sale entry rather than to the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 07:40 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001834249
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	QuantumScape Corp
SEC File Number	001-39345
Address of Issuer	1730 TECHNOLOGY DRIVE SAN JOSE CALIFORNIA 95110
Phone	(408) 452-2000
Name of Person for Whose Account the Securities are To Be Sold	Holme Timothy
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th floor New York NY 10004	22367	157351.85	575291274	02/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	02/24/2026	RSU vesting	Issuer			42321	02/24/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
The Holme 2020 Irrevocable Trust 1730 Technology Dr. San Jose CA 95110	Class A common stock	12/04/2025	44922	570064.67
Timothy Holme 1730 Technology Dr. San Jose CA 95110	Class A common stock	12/04/2025	166440	2112123.60
The Holme 2020 Irrevocable Trust 1730 Technology Dr. San Jose CA 95110	Class A common stock	01/05/2026	44922	506636.53
Timothy Holme 1730 Technology Dr. San Jose CA 95110	Class A common stock	01/05/2026	166440	1877110.64
Timothy Holme 1730 Technology Dr. San Jose CA 95110	Class A common stock	02/18/2026	105719	755309.40
Timothy Holme 1730 Technology Dr. San Jose CA 95110	Class A common stock	02/19/2026	23316	164979.35
Timothy Holme 1730 Technology Dr. San Jose CA 95110	Class A common stock	02/19/2026	127077	902412.54
The Holme 2020 Irrevocable Trust 1730 Technology Dr. San Jose CA 95110	Class A common stock	02/19/2026	34254	243248.10
Timothy Holme 1730 Technology Dr. San Jose CA 95110	Class A common stock	02/20/2026	34120	237722.65

144: Remarks and Signature

Remarks	The number of shares to be sold represents an estimate of the amount necessary to cover tax obligations on the release of restricted stock units.
Date of Notice	02/25/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Timothy Holme
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)